Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to prov...

Source: Orphanet Journal of Rare Diseases - October 8, 2020 Category: Internal Medicine Authors: Krzysztof Piotr Malinowski, Pawe ł Kawalec, Wojciech Trąbka, Christoph Sowada, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar and Marian Sorin Tags: Research Source Type: research